Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Karen M. Anderson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Tia L. Bush - $4.05M of CNTA open-market activity in the last 12 months
- Gregory M. Weinhoff - $2.65M of CNTA open-market activity in the last 12 months
- Iqbal J. Hussain - $2.28M of CNTA open-market activity in the last 12 months
- Mario Alberto Accardi - $515K of CNTA open-market activity in the last 12 months
- Medicxi Ventures Management (Jersey) Ltd - of CNTA open-market activity in the last 12 months
- INDEX VENTURES LIFE VI (JERSEY) L.P. - of CNTA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Karen M. Anderson?
Karen M. Anderson is a corporate insider, tracked as Chief People Officer of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Karen M. Anderson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Karen M. Anderson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($9.93M) across all tracked filings.
Where can I see all of Karen M. Anderson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Karen M. Anderson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
